Your browser doesn't support javascript.
loading
Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease.
Jolles, Stephen; Borte, Michael; Nelson, Robert P; Rojavin, Mikhail; Bexon, Martin; Lawo, John-Philip; Wasserman, Richard L.
Afiliação
  • Jolles S; University Hospital of Wales, Cardiff, UK. Electronic address: jollessr@cardiff.ac.uk.
  • Borte M; Hospital St. Georg GmbH Leipzig, Academic Teaching Hospital of the University of Leipzig, Leipzig, Germany. Electronic address: Michael.Borte@sanktgeorg.de.
  • Nelson RP; Indiana University School of Medicine and the IU-Simon Cancer Center, Indianapolis, IN, USA. Electronic address: ronelson@iu.edu.
  • Rojavin M; CSL Behring, LLC, King of Prussia, PA, USA. Electronic address: Mikhail.Rojavin@cslbehring.com.
  • Bexon M; CSL Behring AG, Berne, Switzerland. Electronic address: Martin.Bexon@cslbehring.com.
  • Lawo JP; CSL Behring, Marburg, Germany. Electronic address: John-Philip.Lawo@cslbehring.com.
  • Wasserman RL; Medical City Children's Hospital, Dallas, TX, USA. Electronic address: drrichwasserman@gmail.com.
Clin Immunol ; 150(2): 161-9, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24412910

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Síndromes de Imunodeficiência / Fatores Imunológicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Síndromes de Imunodeficiência / Fatores Imunológicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article